Mimotopes will be an exhibitor at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting & Pre-Conference Programmes in San Diego, California from 1-5 November 2023.
SITC is the leading member-driven organisation focused on cancer immunotherapy. SITC 38th Annual Meeting is the largest cancer immunotherapy conference and exhibit. SITC’s Annual Meeting brings together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.
Catherine Gineste from Mimotopes’ Sales and Technical Support team will be present at Booth 835 to showcase their latest custom peptide synthesis, catalogue peptides, PepSet™ peptide libraries, reagents, antibodies, and an array of other immunology services for the research market.
Mimotopes is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets, and distributes high quality biochemical products and services for the life-science sector. Our customers range from small labs and universities worldwide, to large multinational drug discovery companies.
For more information, please visit our profile on the Pharmaceutical Technology site.